[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4967 followers
Created: 2025-07-18 14:37:49 UTC

💼Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist

$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1

![](https://pbs.twimg.com/card_img/1946216265728897025/S_RgLz8l?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946217851292983547/c:line.svg)

**Related Topics**
[hims](/topic/hims)
[pfe](/topic/pfe)
[manat](/topic/manat)
[$hims](/topic/$hims)
[$vani](/topic/$vani)
[$zldpf](/topic/$zldpf)
[$rhhby](/topic/$rhhby)
[$gsk](/topic/$gsk)

[Post Link](https://x.com/AponiaAnalytics/status/1946217851292983547)